Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
Top Cited Papers
Open Access
- 14 February 2002
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 346 (7) , 469-475
- https://doi.org/10.1056/nejmoa011931
Abstract
Within a period of three years, we identified 13 patients in whom pure red-cell aplasia developed during treatment with recombinant human erythropoietin (epoetin). We investigated whether there was an immunologic basis for the anemia in these patients.Keywords
This publication has 12 references indexed in Scilit:
- Epoetin alpha and beta in their erythropoetin isoform compositions and biological propertiesBritish Journal of Haematology, 1998
- Antibodies against Recombinant Human Erythropoietin in a Patient with Erythropoietin-Resistant AnemiaNew England Journal of Medicine, 1996
- Autoantibodies against Erythropoietin in a Patient with Pure Red-Cell AplasiaNew England Journal of Medicine, 1996
- Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptorCell, 1995
- Glycosylation of the murine erythropoietin receptorFEBS Letters, 1990
- Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA.Journal of Biological Chemistry, 1987
- Cloning and expression of the human erythropoietin gene.Proceedings of the National Academy of Sciences, 1985
- Anemia of end-stage renal disease (ESRD)Kidney International, 1985
- Isolation and characterization of genomic and cDNA clones of human erythropoietinNature, 1985
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949